Page 24 - வீரர்கள் வாழ்க்கைத்தொழில்கள் கனடா News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Creso Pharma Ltd enters transformational deal to buy established psychedelics company Halucenex Life Sciences Inc
proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.
Creso Pharma Ltd enters transformational deal to buy established psychedelics company Halucenex Life Sciences Inc
proactiveinvestors.com.au - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com.au Daily Mail and Mail on Sunday newspapers.
With two pandemics under his belt, senior celebrates 106th birthday
timescolonist.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from timescolonist.com Daily Mail and Mail on Sunday newspapers.
PORT HAWKESBURY, N.S. A doctor who saw Lionel Desmond two months after he returned to Nova Scotia in 2016 told an inquiry Wednesday the former soldier was looking for help getting followup psychiatric treatment. Desmond s medical care is at the centre of the inquiry, which is trying to determine why the Afghanistan war veteran fatally shot his wife, daughter and mother inside their home in Upper Big Tracadie, N.S., on Jan. 3, 2017. Dr. Luke Harnish told the fatality inquiry that he was filling in as a physician at the Guysborough Memorial Hospital on Oct. 13, 2016 when he saw Desmond and his wife, Shanna Desmond. Harnish said it was the first and only time he saw Desmond.
Article content
Prior to the pandemic, the lifetime prevalence of major depressive disorder in Canada was between 4.7-11.2 per cent, which has equated to a $51 billion burden on the Canadian economy through lost productivity, lowered quality of life, and related healthcare costs. Early reports suggest that these figures have grown significantly, with rates of depression symptoms and suicidal ideation tripling since the start of the pandemic with over half the population reporting worsened mental health due to the impact of the pandemic. Current treatment approaches such as antidepressants struggle with high drop-out, relapse, and non-adherence rates, as well as negligible improvements in symptoms. These issues have warranted an exploration of novel treatment approaches and there is a growing body of research that supports psychedelic-assisted therapy’s ability to address them.